APA (7th ed.) Citation

MIH, B., K, H., MT, S., F, C., I, J., Z, W., . . . G, C. (2024). SPAK inhibitor ZT-1a attenuates reactive astrogliosis and oligodendrocyte degeneration in a mouse model of vascular dementia. CNS neuroscience & therapeutics, 30(3), e14654. https://doi.org/10.1111/cns.14654

Chicago Style (17th ed.) Citation

MIH, Bhuiyan, et al. "SPAK Inhibitor ZT-1a Attenuates Reactive Astrogliosis and Oligodendrocyte Degeneration in a Mouse Model of Vascular Dementia." CNS Neuroscience & Therapeutics 30, no. 3 (2024): e14654. https://doi.org/10.1111/cns.14654.

MLA (9th ed.) Citation

MIH, Bhuiyan, et al. "SPAK Inhibitor ZT-1a Attenuates Reactive Astrogliosis and Oligodendrocyte Degeneration in a Mouse Model of Vascular Dementia." CNS Neuroscience & Therapeutics, vol. 30, no. 3, 2024, p. e14654, https://doi.org/10.1111/cns.14654.